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BACKGROUND: Ozone therapy has become a useful
treatment for pathological processes, in which the
damage mediated by reactive oxygen species is
involved. Several lines of evidence suggest that
cisplatin-induced acute nephrotoxicity is partially
mediated by reactive oxygen species.
Aims: To analyze the effect of ozone administration
after cisplatin-induced acute nephrotoxicity.
Methods: Male Sprague 
/Dawley rats were treated
with five intra-rectal applications of ozoneuoxygen
mixture at 0.36, 1.1 and 1.8 mgukg after cisplatin
intraperitoneal injection (6 mgukg). Serum and
kidneys were taken off 5 days after cisplatin
treatment. Creatinine was measured in the serum
and the activities of antioxidant enzymes and
thiobarbituric acid reactive substances and glu-
tathione content were analyzed in renal homoge-
nate.
Results: Ozone treatment diminished the increase
in serum creatinine levels, the glutathione deple-
tion and also reversed the inhibition of superoxide
dismutase, catalase and glutathione peroxidase ac-
tivities induced by cisplatin in the rat kidney. Also,
the renal content of thiobarbituric reactive sub-
stances was decreased by ozoneuoxygen mixture
applied after cisplatin.
Conclusion: Intrarectal applications of ozone re-
versed the renal pro-oxidant unbalance induced
by cisplatin treatment by the way of stimulation
to some constituents of antioxidant system in the
kidney, and thereby it decreased the renal damage.
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Introduction
Cisplatin (CDDP) is one of the most effective
chemotherapeutic agents for the treatment of
ovarian, testicular and bladder carcinomas, and
cancers of the head and neck and lung.
1 Unfortu-
nately, more than 25) of patients receiving an
initial dose (50 /100 mgum
2) of CDDP develop
acute renal failure
1 due to its preferential accumu-
lation within the proximal tubule cells in the outer
medulla of the kidney.
2 The cellular events in
CDDP-induced acute nephrotoxicity, including de-
creased protein synthesis, membrane lipid perox-
idation, mitochondrial dysfunction and DNA injury,
are a consequence of free radical generation and
the inability to scavenge such molecules.
3 Further-
more, various studies have demonstrated a protec-
tive role for antioxidants and free radical
scavengers such as vitamin E, lipoic acid, ebselen,
superoxide dismutase (SOD), taurine, glutathione
(GSH) and its esters in CDDP-induced acute
nephrotoxicity.
4 9
Very recently, studies from our laboratory have
demonstrated that ozone (O3) pretreatment under
an oxidative preconditioning regimen for 15 days
exerts protection against CDDP-induced acute
renal damage in rats, and it was due to the O3
protective effects on some important constituents
of the antioxidant system in the kidney such as
SOD, catalase (CAT), glutathione peroxidase (GSH-
Px), GSH, and the concomitant reduction of renal
lipid peroxidation.
10 Taking into account these
findings we decided to elucidate whether ozone
therapy administered after CDDP-induced acute
nephrotoxicity is able to reverse it.
Materials and methods
Chemicals
Serum creatinine was measured spectrophotometri-
cally with the creatinine assay kits purchased from
Biological Products Enterprise ‘Carlos J Finlay’
(Havana, Cuba). All reagents used in determina-
tions of GSH, SOD, CAT, GSH-Px, thiobarbituric
acid reactive substances (TBARS) and cisplatin were
purchased from Sigma Chemicals (St Louis, MO,
USA). Other reagents of analytical grade were
obtained from normal commercial sources.
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307Animals
Male Sprague /Dawley rats (200 /250 g) were ob-
tained from the National Center for Laboratory
Animal Production (CENPALAB, Havana Cuba). The
animals were housed under a 12 h light /dark cycle
with room temperature maintained at 258C, humidity
at 60) and food and water available ad libitum. The
experiments were conducted in accordance with the
ethical guidelines for investigations in laboratory
animals and were approved by the Ethical Committee
for Animal Experimentation of the National Center for
Scientific Research, Havana, Cuba.
Experimental design
An ozoneuoxygen mixture (OOM) was generated by
OZOMED 01 equipment manufactured by the Ozone
Research Center (Cuba). The OOM was obtained
from medical-grade oxygen and it was used imme-
diately. The O3 concentration was measured by an
ultraviolet spectrophotometer at 254 nm.
The rats were divided into six groups of eight rats
each: (1) non-treated control rats, (2) rats treated only
with CDDP, (3) rats treated with CDDP plus oxygen
(O2), (4) rats treated with CDDP plus OOM (10 mgo f
O3uml at a dose of 0.36 mgukg), (5) rats treated with
CDDP plus OOM (30 mgo fO 3uml at a dose of 1.1
mgukg), and (6) rats treated with CDDP plus OOM (50
mgo fO 3uml at a dose of 1.8 mgukg).
CDDP (6 mgukg) was administered to rats by an
intraperitoneal injection and thereafter OOM was
administered once daily by rectal insufflation during
5 days. The volume of insufflated mixture was
approximately 9 ml.
Twenty-four hours after the last OOM application
the rats were killed by ether overdose, and afterwards
the blood was collected and serum was separated by
centrifugation for creatinine analysis. The kidneys
were removed and immediately frozen at   /208C
until biochemical and histopathological studies were
performed.
Kidney homogenates were obtained using a tissue
homogenator at 48C. The homogenates were pre-
pared with a 100 mM KCl buffer (pH 7) containing
ethylenediamine tetraacetic acid 0.3 mM (1:10 wuv)
for GSH, TBARS, GSH-Px and SOD determinations
(Buffer 1). The homogenates were spun down with a
centrifuge at 600  /g for 60 min at 48C. The super-
natants were taken for biochemical determinations.
Kidney homogenates for CAT enzymatic assay
were obtained with a 50 mM phosphate buffer (pH
7) containing 1) Triton X-100 (1:9 wuv) (Buffer 2).
The homogenates were centrifuged at 600  /g for 60
min at 48C and the supernatants were used for the
CAT assay.
Determination of GSH
GSH was determined by a slightly modified version
of the method of Beutler et al.,
11 using a spectro-
photometer. One milliliter of the kidney homogenate,
as already described, was mixed with 1.5 ml of 5)
metaphosphoric acid and centrifuged at 3000  /g for
10 min at room temperature. Five hundred microliters
of this acidic supernatant was mixed with 2 ml of 0.2
M phosphate buffer and 0.25 ml of 0.04) 5,5?-dithio-
bis-2-nitrobenzoic acid. Absorbance of the yellow
solution was measured at 412 nm within 10 min. A
molar extinction coefficient of 13.6 Mucm that de-
scribes the formation of the thiolate anion by the
reaction of sulfhydryl groups with 5,5?-dithio-bis-2-
nitrobenzoic acid at 412 nm was used to quantify
GSH.
Determination of SOD
The enzymatic activity of SOD was determined by a
modified version of the method of Minami and
Yoshikawa.
12 Fifty microliters of the kidney homo-
genate was mixed with 450 ml of cold deionized
water, 125 ml of chloroform and 250 ml of ethanol.
The mixture was centrifuged at 8000  /g for 2 min at
48C. Five hundred microliters of the extract was
added to a reaction mixture containing 500 mlo f
72.4 mM Tris /Cacodylate buffer with 3.5 mM diethy-
lene pentaacetic acid (pH 8.2), 100 mlo f1 6 )
Triton-X 100 and 250 ml of 0.9 mM nitro-blue
tetrazolium. The reaction mixture was incubated for
5 min at 378C before adding 10 ml of 9 mM pyrogallol
(dissolved in 10 mM hydrochloric acid), and then
incubated for 5 min at 378C. The reaction was
stopped with the addition of 300 ml of 2 M formic
buffer (pH 3.5) containing 16) Triton-X 100. The
absorbance was measured at 540 nm on the spectro-
photometer. One unit of SOD enzymatic activity is
FIG. 1. Light micrograph of the corticomedulary region of a
rat kidney from the control group. Normal histology (hema-
toxylin and eosin,  /100).
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initial absorbance of nitro-blue tetrazolium by 50).
Determination of CAT
CAT was determined according to the method of Rice
Evans and Diplock.
13 Kidney homogenate was di-
luted with Buffer 2, as already described, to obtain an
adequate dilution of the enzyme. Then, 2 ml of buffer
2 were added to the cuvette and mixed with 1 ml of
30 mM H2O2, and then the absorbance was measured
at 240 nm, for 30 sec in the spectrophotometer. The
initial absorbance of the reaction mixture must be
around 0.5. The enzyme activity is expressed as the
first-order constant that describes the decomposition
of H2O2 at room temperature.
Determination of GSH-Px
The enzymatic activity of GSH-Px was determined
using a modified version of the method of Thonson
et al.
14 All reaction mixtures were dissolved in 20 mM
sodium phosphate buffer containing 6 mM ethylene-
diamine tetraacetic acid (pH 7.0). The reaction
mixture consisted of 98.8 ml of phosphate buffer,
700 ml of 2.86 mM GSH, 100 ml of 1 mM sodium azide,
100 ml of 1 mM NADPH and 4.2 ml of GSH reductase
(0.5 units). Then, 10 ml of the tissue homogenate
supernantant were added to the reaction mixture and
incubated at room temperature for 10 /15 min.
Afterwards, 10 mlo f3 0m Mt-butyl hydroperoxide
(dissolved in bi-distilled water) was added to the
reaction mixture and measured at 340 nm for 7 min in
the spectrophotometer. A molar extinction coefficient
of 6.22  /10
3 Mucm was used to determine the activity
of GSH-Px. The enzyme activity is expressed as
international units of enzymatic activityumilligram of
protein. International units are expressed as micro-
moles of transformed hydroperoxides per minute per
milliliter of enzyme.
Lipid peroxidation assay
This assay is used to determine TBARS levels as
described by Ohkawa et al.
15 Two hundred milliliters
of tissue homogenate supernatant were added to 100
ml of sodium dodecyl sulfate, 750 mlo f2 0 ) acetic
acid (pH 3.5), 750 ml of 0.6) thiobarbituric acid and
300 ml of distilled water and were incubated at 958C
for 60 min. The samples were allowed to cool at
room temperature. Then 2.5 ml of butanol:pyridine
(15:1) and 500 ml of distilled water were added,
vortexed, and centrifuged at 2000  /g for 15 min. The
absorbance of 3 ml of the colored layer was
measured at 532 nm spectrophotometrically using
1,1,3,3-tetraethoxypropane as the standard.
Protein assay
Protein concentrations were determined by the
method of Lowry et al.
16 using bovine serum albumin
as standard.
Histopathological assessment of renal damage
The left kidneys were quickly removed and fixed in
10) formaldehyde. Tissues were embedded in
paraffin, sectioned at 3 mm, stained with hematoxylin
and eosin and evaluated by light microscopy.
Statistical analysis
Data are expressed as the mean9 /standard error of
the mean and analyzed statistically using one-way
analysis of variance followed by the Duncan multiple
range test for serum creatinine determinations,
whereas the Kruskall /Wallis test followed by the
Mann /Whitney test was applied for the rest of the
markers. The 0.05 level of probability was used as
statistical significance.
Results
Serum creatinine levels significantly increased in
CDDP-injected rats as compared with non-treated
control (pB /0.01). Graded doses of OOM (0.36, 1.1
and 1.8 mgukg) significantly reduced in 50) the
increase of serum creatinine levels as compared with
CDDP alone and CDDP plus O2, indicating that O3
treatment ameliorated the nephrotoxicity of CDDP
(Table 1).
Also, O3 treatment induced reversion of the renal
GSH depletion induced by CDDP. This effect was
significantly greater at an O3 dose of 1.1 mgukg as
compared with CDDP-treated or non-treated rats. In
agreement with that finding, the OOM significantly
reduced, the renal TBARS content at an O3 dose of
1.1 mgukg, although the other two tested doses did
not induce any significant change with respect to
CDDP-treated control rats.
The SOD activity in the kidney significantly de-
creased (44) of control) in CDDP-treated rats. The
treatment with OOM induced reversion of SOD
activity up to values very close to those of the
non-treated control group. Thus, O3 treatment ex-
erted a stimulating effect in renal SOD activity as
compared with CDDP alone. This effect was dose
dependent.
CAT activity in the kidney significantly decreased
(48) of control) in CDDP-treated rats as compared
with the control group. The treatment with OOM
induced also in a dose-dependent fashion a signifi-
cant reversion of that effect. The increase of renal
CAT activity by O3 treatment was greater with doses
Ozone treatment of acute nephrotoxicity
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CDDP plus O2 treatment, and was very close to
values of the non-treated control group.
Also, GSH-Px activity in the kidney was signifi-
cantly decreased in CDDP-treated rats with respect to
non-treated rats. O3 treatment also significantly
increased GSH-Px activity as compared with CDDP
alone. O3 doses of 1.1 and 1.8 mgukg also induced
values of enzyme activity that reached those of non-
treated rats.
The histopathological changes observed in the
kidneys in this experiment revealed that in rats
treated with CDDP alone, severe and widespread
tubular necrosis with dilation of proximal tubules,
dequamation of renal tubular cells, and cast forma-
tion in the lumen was observed. Characteristically,
the tubular lesions were mostly localized in the
corticomedulary region 5 days after CDDP adminis-
tration (Fig. 2).
In contrast, in rats treated with CDDP and there-
after with five i.r. applications of OOM (1.1 mgukg of
O3) the tubular necrosis was slight, and in a lesser
extent than it occurred in rats treated with CDDP
alone. Tubular dilation and cast formation in the
tubular lumen were also reduced in rats treated with
O3 (Fig. 3)
Discussion
To date different strategies have been proposed to
inhibit CDDP-induced nephrotoxicity. One of them is
the use of antioxidant therapies to prevent the
generation of reactive oxygen species, which exert
FIG. 2. Light micrograph of the corticomedulary region of a
rat kidney treated with CDDP alone. Typical severe tubular
necrosis with dilation of proximal tubules is shown. Arrows
indicate dequamation of renal tubular cells and cast forma-
tion in the tubular lumen (hematoxylin and eosin,  /400).
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310 Mediators of Inflammation Vol 13  2004an influence on the progression of oxidative renal
damage induced by CDDP.
17 Thus, a proposal
has been the use of enriched diets with natural
antioxidants like vitamin E, ascorbic acid and methio-
nine among others.
4,18 Another proposal has been
the use of sulfhydryl-containing drugs such as
diethyldithiocarbamate, sodium thiosulfate, N-acetyl-
cysteine and lipoic acid, which also exert antioxidant
activity.
5
However, although in animal models all these
compounds have shown protective effects in
CDDP-induced acute nephrotoxicity, none of them
has proved to be clinically efficacious as a complete
protective agent in patients.
5
Very recently, it was demonstrated in our labora-
tory that O3 pretreatment under an oxidative pre-
conditioning regimen for 15 days exerted protective
effects on some important constituents of the en-
dogenous antioxidant system in the kidney such as
SOD, CAT, GSH-Px and GSH in CDDP-induced acute
nephrotoxicity.
10 Our present results also demon-
strate that i.r. O3 therapy for 5 days after CDDP
administration attenuates its nephrotoxicity and also
restores the levels of antioxidant defense constituents
(GSH, SOD, CAT and GSH-Px) depressed by CDDP
up to values close to those of non-treated control rats
(Table 1).
Furthermore, the stimulant effects of O3 therapy on
antioxidant system were accompanied by a decrease
in both serum creatinine levels and renal TBARS
content, the latter used as marker of lipid peroxida-
tion in the kidney. Thus, all these aforementioned
effects of O3 explain by which mechanisms attenu-
ated acute renal damage is induced by CDDP.
Induction of CAT, SOD and GSH-Px by ozone
therapy is probably due to H2O2 produced as result
of O3 decomposition, because it is one of the major
O3 intermediates along with OH+ and O2  . Whiteside
and Hassan
19 also demonstrated induction of CAT
and SOD by O3 in cultures of Escherichia coli.
Furthermore, they showed that an increase in the
activities of CAT and SOD by O3 was due to induction
of the novo enzyme synthesis rather than activation
of pre-existing apoproteins.
Induction of CAT and SOD might be related with
activation of geneuregulatory nuclear factor-kappa B
(NF-kB) by H2O2. This transcription factor appears to
play many roles in stress responses, inflammation,
cell cycle regulation and apoptosis,
20 and it has been
closely related with the release of cytokines after
ozonation of blood ex vivo.
21 However, we found no
nuclear expression of NF-kB 5 days after cisplatin
injection in rats (unpublished results), which might
suggest that NF-kB is not directly related with the
induction of antioxidant enzymes observed in this
experiment, but may be influencing the diminution in
inflammatory responses induced by this drug in renal
tissue
22 detected after the fifth day in ozone-treated
rats previously injected with cisplatin (unpublished
data).
Other proteins that might be involved in ozone-
induced recovery in cisplatin nephropathy are the
Bcl-2 family of proto-oncogenes (unpublished re-
sults). Within 5 days after cisplatin administration,
levels of pro-apoptotic Bax mRNA were significantly
increased, as reported by other authors,
23 and we
detected a significant decrease in the expression of
this protein with five applications of ozone after
cisplatin injection, which is correlated with an
increase in the expression of BcluXL (unpublished
data), favoring the survival and regeneration of the
renal tissue.
Thus, the induction of SOD, CAT and GSH-Px in
response to O3 treatment in CDDP-induced nephro-
toxicity provides further evidence that there is a
correlation between antioxidant enzyme biosynthesis
and O3 exposure, which supports the potential
usefulness of this therapy in the prevention and
treatment of this toxic nephropathy.
Rectal insufflation of O3 is a simple procedure and
it was reported free of side effects in humans;
however, the accurate measurement of the O3 dosage
is difficult to assess,
24 although it is the most useful
and easy method to perform in rats. Autohemother-
apy, in which a volume of blood is extracted and
exposed to a precise ozone dose, represents the most
suitable method of application in humans, because
there is a reasonable stoichiometric relationship
between O3 and blood.
25 Therefore, autohemother-
apy might be promissory for the treatment of cisplatin
nephrotoxicity.
FIG. 3. Light micrograph of the corticomedulary region of a
rat kidney treated with OOM after CDDP injection. Tubular
necrosis was slight and in lesser extent than in Fig. 2. Note
the signiﬁcant diminution in the dequamation of tubular
epithelial cells (hematoxylin and eosin,  /400).
Ozone treatment of acute nephrotoxicity
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